ABSTRACT
Introduction: Neuropsychiatric diseases are responsible for one of the highest burden of morbidity and mortality worldwide. These illnesses include schizophrenia, bipolar disorder, and major depression. Individuals affected by these diseases may present mitochondrial dysfunction and oxidative stress. Additionally, patients also have increased peripheral and neural chronic inflammation. The Brazilian fruit, açaí, has been demonstrated to be a neuroprotective agent through its recovery of mitochondrial complex I activity. This extract has previously shown anti-inflammatory effects in inflammatory cells. However, there is a lack of understanding of potential anti-neuroinflammatory mechanisms, such as cell cycle involvement. Objective: The objective of this study is to evaluate the anti-neuroinflammatory potential of an açaí extract in lipopolysaccharide-activated BV-2 microglia cells. Methods: Açaí extract was produced and characterized through high performance liquid chromatography. Following açaí extraction and characterization, BV-2 microglia cells were activated with LPS and a dose-response curve was generated to select the most effective açaí dose to reduce cellular proliferation. This dose was then used to assess reactive oxygen species (ROS) production, double-strand DNA release, cell cycle modulation, and cytokine and caspase protein expression. Results: Characterization of the açaí extract revealed 10 bioactive molecules. The extract reduced cellular proliferation, ROS production, and reduced pro-inflammatory cytokines and caspase 1 protein expression under 1 μg/mL in LPS-activated BV-2 microglia cells but had no effect on double strand DNA release. Additionally, açaí treatment caused cell cycle arrest, specifically within synthesis and G2/Mitosis phases. Conclusion: These results suggest that the freeze-dried hydroalcoholic açaí extract presents high anti-neuroinflammatory potential.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
Notes on contributors
Diulie Valente de Souza
Diulie Valente de Souza is a bachelor in Biomedicine and currently is a Ph.D. student in Nanoscience.
Lauren Pappis
Lauren Pappis is master in Pharmaceutical Sciences and currently is a Ph.D. student in Pharmaceutical Sciences
Thuany Teixeira Bandeira
Thuany Teixeira Bandeira is a Bachelor in Biomedicine and currently is a master student in Nanoscience.
Gabriela Geraldo Sangoi
Gabriela Geraldo Sangoi is a Biomedicine undergrad student.
Tuyla Fontana
Tuyla Fontana is a Biomedicine undergrad student.
Vitor Braga Rissi
Vitor Braga Rissi is Ph.D. in Veterinary Medicine and currently is an assistant professor at the Federal University of Santa Catarina.
Michele Rorato Sagrillo
Michele Rorato Sagrillo is Ph.D. in Pharmacology and currently is associate professor at the Franciscan University.
Marta Maria Duarte
Marta Maria Duarte is Ph.D. in Biological Sciences and currently is an associate professor at the Lutheran University of Brazil.
Thiago Duarte
Thiago Duarte is Ph.D. in Pharmacology.
David Frederick Bodenstein
David Frederick Bodenstein is currently a Ph.D. student from the University of Toronto.
Ana Cristina Andreazza
Ana Cristina Andreazza is Ph.D. in Biological Sciences and currently is a associate professor at the University of Toronto.
Ivana Beatrice Mânica da Cruz
Ivana Beatrice Mânica da Cruz is Ph.D. in Molecular Biology and currently is an associate professor at the Federal University of Santa Maria.
Euler Esteves Ribeiro
Euler Esteves Ribeiro is Ph.D. in Biomedical gerontology and currently is the dean of University of the Elderly Foundation.
Alfredo Antoniazzi
Alfredo Antoniazzi is Ph.D. in Veterinary Medicine and currently is associate professor at the Federal University of Santa Maria.
Aline Ferreira Ourique
Aline Ferreira Ourique is Ph.D. in Pharmaceutical Sciences and currently is assistant professor at the Franciscan University.
Alencar Kolinski Machado
Alencar Kolinski Machado is Ph.D. in Pharmacology and currently is assistant professor at the Franciscan University.